Search - tctmd.com

Displaying 721 - 740 of 1503

Sort: Relevancy | Date

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Daily News

Long Bouts of Sedentary Time Linked to CVD Risk in Women

Michael O'Riordan

February 20, 2019

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Lucy Hicks

February 15, 2019

News Daily News

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Caitlin E. Cox

February 13, 2019

News Daily News

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

L.A. McKeown

February 08, 2019

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

African-American ACS Patients Less Often Treated With Prasugrel After PCI

Yael L. Maxwell

January 24, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Michael O'Riordan

January 07, 2019

News Daily News

Many PCI Patients Treated in China Have No Angina Symptoms

Caitlin E. Cox

December 20, 2018

News Conference News WCC 2018

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

Todd Neale

December 14, 2018

News Daily News

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

Caitlin E. Cox

December 14, 2018

News Conference News WCC 2018

Man’s Best Friend, Especially After an MI or Stroke

Todd Neale

December 11, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Advertisement

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Long Bouts of Sedentary Time Linked to CVD Risk in Women

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

African-American ACS Patients Less Often Treated With Prasugrel After PCI

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Many PCI Patients Treated in China Have No Angina Symptoms

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

Man’s Best Friend, Especially After an MI or Stroke

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content